Orbimed Advisors - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 53 filers reported holding HARPOON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$441,065
-4.6%
621,2180.0%0.01%
-11.1%
Q1 2023$462,310
-58.0%
621,218
-59.0%
0.01%
-57.1%
Q4 2022$1,100,521
-62.5%
1,516,496
-49.9%
0.02%
-61.1%
Q3 2022$2,935,000
-49.4%
3,025,908
-0.4%
0.05%
-48.6%
Q2 2022$5,805,000
-61.6%
3,039,5080.0%0.10%
-57.1%
Q1 2022$15,106,000
-31.1%
3,039,508
+4.7%
0.24%
-13.1%
Q4 2021$21,921,000
+6.3%
2,903,508
+11.2%
0.28%
+24.2%
Q3 2021$20,629,000
-43.0%
2,611,3080.0%0.23%
-38.0%
Q2 2021$36,219,000
-24.3%
2,611,308
+14.2%
0.37%
-18.1%
Q1 2021$47,817,000
+56.8%
2,285,704
+24.5%
0.45%
+67.4%
Q4 2020$30,491,000
-2.2%
1,835,7040.0%0.27%
-31.9%
Q3 2020$31,189,000
+2.3%
1,835,7040.0%0.39%
-8.6%
Q2 2020$30,473,000
+7.6%
1,835,704
-25.0%
0.43%
-9.9%
Q1 2020$28,329,000
-21.7%
2,446,4090.0%0.48%
-7.9%
Q4 2019$36,182,000
+8.3%
2,446,4090.0%0.52%
-18.5%
Q3 2019$33,418,000
+5.1%
2,446,4090.0%0.63%
+28.6%
Q2 2019$31,803,000
+37.3%
2,446,4090.0%0.49%
+37.3%
Q1 2019$23,167,0002,446,4090.36%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 315,668$1,272,1421.63%
MPM ASSET MANAGEMENT LLC 313,136$1,261,9380.68%
View complete list of HARPOON THERAPEUTICS INC shareholders